Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001596551 | SCV001831799 | pathogenic | not provided | 2024-06-21 | criteria provided, single submitter | clinical testing | Initiation codon variant in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26888482, 29709707, 25590979) |
Duke University Health System Sequencing Clinic, |
RCV003223424 | SCV003919038 | likely pathogenic | Pontocerebellar hypoplasia type 2D | 2023-04-20 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001596551 | SCV004526239 | pathogenic | not provided | 2023-11-05 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the SEPSECS mRNA. The next in-frame methionine is located at codon 61. This variant is present in population databases (no rsID available, gnomAD 0.01%). Disruption of the initiator codon has been observed in individual(s) with clinical features of pontocerebellar hypoplasia (PMID: 25590979, 35091508). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 1223757). For these reasons, this variant has been classified as Pathogenic. |